Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN.
Vanderbilt University School of Medicine, Nashville, TN.
JCO Oncol Pract. 2022 Jun;18(6):e974-e987. doi: 10.1200/OP.21.00644. Epub 2022 Feb 24.
Prior authorization (PA) imposes significant time burdens on radiation oncology practices, but its financial impact has not been characterized. We used time-driven activity-based costing (TDABC) to assess the cost burden of treatment-related PA events at an academic radiation oncology practice. We then estimated annual costs for an academic practice and academic practices nationally.
Using internal analyses, we created TDABC process maps for treatment-related PA events at an academic radiation oncology practice. Using published compensation data, internal workhour estimates, and supervisory requirements, we calculated the cost of each PA event and annual costs. Using data from the 2017 American Society for Radiation Oncology Workforce Survey and the 2018 American Society for Radiation Oncology Prior Authorization Survey, we estimated annual PA costs for academic medical centers nationally.
We successfully created TDABC process maps for treatment-related PA events at an academic radiation oncology practice. There were significant time and cost burdens for all events (range: 51-95 minutes, $28-$101 US dollars [USD]), with significant increases when peer-to-peer discussion was required (range: 92-95 minutes, $75-$101 USD). Annual treatment-related PA departmental costs were estimated to be $491,989 USD, with approved treatments accounting for the majority (94%; $463,027 USD). Nationally, annual treatment-related PA costs were estimated to be $40,125,848 USD, with approved treatments accounting for the majority (86%; $34,632,620 USD).
TDABC can be used to estimate the cost burden of PA events. These burdens are significant and translate into massive organizational costs. Our national estimates highlight the tremendous cost of PA for academic radiation oncology practices, with the majority of costs related to approved treatments.
预先授权(PA)给放射肿瘤学实践带来了巨大的时间负担,但尚未对其财务影响进行描述。我们使用时间驱动的作业成本法(TDABC)来评估学术放射肿瘤学实践中与治疗相关的 PA 事件的成本负担。然后,我们估计了学术实践和全国学术实践的年度成本。
我们使用内部分析为学术放射肿瘤学实践中的与治疗相关的 PA 事件创建了 TDABC 流程图。使用已发表的薪酬数据、内部工作时间估算和监督要求,我们计算了每个 PA 事件的成本和年度成本。使用 2017 年美国放射肿瘤学会劳动力调查和 2018 年美国放射肿瘤学会预先授权调查的数据,我们估计了全国学术医疗中心的年度 PA 成本。
我们成功地为学术放射肿瘤学实践中的与治疗相关的 PA 事件创建了 TDABC 流程图。所有事件都存在显著的时间和成本负担(范围:51-95 分钟,28-101 美元[USD]),当需要同行讨论时,负担会显著增加(范围:92-95 分钟,75-101 美元)。估计与治疗相关的 PA 部门年度成本为 491,989 美元,其中已批准的治疗方案占大多数(94%;463,027 美元)。全国范围内,与治疗相关的 PA 年度成本估计为 40,125,848 美元,其中已批准的治疗方案占大多数(86%;34,632,620 美元)。
TDABC 可用于估算 PA 事件的成本负担。这些负担是巨大的,转化为巨大的组织成本。我们的国家估计强调了 PA 对学术放射肿瘤学实践的巨大成本,其中大部分成本与已批准的治疗方案有关。